{"title": "PDF", "author": "PDF", "url": "https://www.uab.edu/medicine/icos/images/POCC_Report/Bi-weekly_POCC_Report/Vaccine.11.17.2021.pdf", "hostname": "PDF", "description": "PDF", "sitename": "PDF", "date": "PDF", "cleaned_text": "Age: Median (Range) 18y (0-39) N % Gender Female 20 42% Race / Ethnicity Non -Hispanic White 22 45% Hispanic or Latino 13 28% Black 8 17% Insurance Public/Uninsured 20 42% Private 26 54% Vaccination Location Oncology Office 17 35% *To report cases, find the POCC report, a copy this report and FAQs, visit: https://www.uab.edu/medicine/icos/icos -research/the -pocc -report Allergic Reaction History History of Allergic Reaction 13 33% To Previous Vaccines 1 2% To Pegylated Asparaginase 3 8% ToEtoposide 0 0% Other 10 26%Median Between Last Chemotherapy and Vaccine :8 days (IQR: 2-56)Patients, Vaccines, and Reactogenicity Local/Systemic Reactions: Chills, Fatigue, Fever, Headache, Injection Site Pain, "}